Views and analysis

Rare Youth Project: Can you empower the next generation of rare disease advocates?

https://pharmaphorum.com/views-analysis-patients/rare_youth_project_empower-next-generation-rare-disease-advocates/

Digital health round-up: Google hires Geisinger CEO to lead move into health sector

https://pharmaphorum.com/views-and-analysis/digital-health-round-up-google-hires-geisinger-ceo-to-lead-move-into-health-sector/

Frontiers Health 2018 Live Day Two

https://pharmaphorum.com/views-analysis-digital/frontiers-health-2018-live-day-two/

Patient centricity is about delivering with, not for, patients

https://pharmaphorum.com/views-analysis-patients/patient-centricity-delivering/

Frontiers Health 2018 Live Day One

https://pharmaphorum.com/views-analysis-digital/frontiers-health-2018-live-day-one/

Exclusive – The Future of pharma in a digital world

https://pharmaphorum.com/digital/healthlive-the-future-of-pharma-in-a-digital-world/

AstraZeneca may have hit rock bottom, but can it rise to new heights?

https://pharmaphorum.com/views-analysis-sales-marketing/astrazeneca-rise-new-heights/

Brand planning in complex and uncertain markets

https://pharmaphorum.com/views-analysis-sales-marketing/brand-planning-in-complex-and-uncertain-markets/

Are dual ARVs the new frontier in a maturing HIV market?

https://pharmaphorum.com/sales-marketing/are-dual-arvs-the-new-frontier-in-a-maturing-hiv-market/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search